Your browser doesn't support javascript.
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli.
Della-Torre, Emanuel; Campochiaro, Corrado; Cavalli, Giulio; De Luca, Giacomo; Ciceri, Fabio; Zangrillo, Alberto; Dagna, Lorenzo.
  • Della-Torre E; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy dellatorre.emanuel@hsr.it.
  • Campochiaro C; Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.
  • Cavalli G; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy.
  • De Luca G; Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.
  • Ciceri F; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy.
  • Zangrillo A; Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.
  • Dagna L; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy.
Ann Rheum Dis ; 2020 Jul 31.
Article in English | MEDLINE | ID: covidwho-1992974

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-218612

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-218612